Eurofins Scientific announces that it has successfully closed the acquisition of Laboratoire Dermscan SAS (“Dermscan”), a leading provider of Cosmetic & Personal Care Products Testing services in Europe.
Dermscan was founded in 1990 in Lyon as a family-owned business. After nearly three decades of scientific innovation and organic growth, Dermscan became one of the European market leaders in Cosmetic Clinical Testing. Dermscan offers a portfolio of more than 200 different tests and clinical studies in dermatology to evaluate the safety and efficacy of cosmetics and pharmaceutical products in this field. Dermscan employs over 150 staff in its laboratories in France, Poland, Tunisia, Mauritius and Thailand, and is expected to generate revenues of over EUR 12m in 2018.
Following the acquisition of CRL in the U.S. in September, Eurofins became the global leader in Cosmetic & Personal Care product Testing, with a network of 40 state-of-the-art laboratories across Europe, North America, Asia, Australia and Africa, offering an unmatched range of chemical, clinical and microbiological testing services to its clients.
Comment from Dr. Frédérique Girard-Ory, Dermscan Group CEO: “This is a new adventure and a new challenge for the entire Dermscan’s team that we are very excited to undertake. Joining Eurofins will enable us to propose an even more complete and diversified offer to the cosmetics industry.”
Comment from Dr. Gilles Martin, Eurofins CEO: “We are very pleased to welcome Dermscan, a renowned family-owned testing company, to Eurofins’ network of businesses. The acquisition of Dermscan significantly expands our testing capabilities for the Cosmetics & Personal Care Products testing market. In return, Dermscan will gain access to the Group’s entire portfolio of tests, logistics and clients, as well as the Group’s IT systems, which should lead to improved process optimization to the benefit of Dermscan’s customers.”